U.S. patent officials reexamining claims about who deserves rights to enormously valuable aspect of the invention.
Surprise patent ruling revives high-stakes dispute over the genome editor CRISPR
Posted in biotech/medical, innovation
Posted in biotech/medical, innovation
U.S. patent officials reexamining claims about who deserves rights to enormously valuable aspect of the invention.